Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "RMAT"

1651 News Found

Max Healthcare teams up with Google to enable direct appointment bookings
Hospitals | January 15, 2026

Max Healthcare teams up with Google to enable direct appointment bookings

The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide


BioNTech maps pivotal oncology milestones for 2026
News | January 15, 2026

BioNTech maps pivotal oncology milestones for 2026

BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company


BD announces $110 million investment in Nebraska to expand prefillable syringe production
News | January 15, 2026

BD announces $110 million investment in Nebraska to expand prefillable syringe production

The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products


ISVIR 2026 showcases cutting-edge interventional radiology in India
News | January 14, 2026

ISVIR 2026 showcases cutting-edge interventional radiology in India

Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine


Merck scores FDA nod for TGT drug Pimicotinib, promising new hope for patients
Drug Approval | January 14, 2026

Merck scores FDA nod for TGT drug Pimicotinib, promising new hope for patients

The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes


Metropolis Healthcare launches Genomics Centre to scale precision diagnostics and research
R&D | January 14, 2026

Metropolis Healthcare launches Genomics Centre to scale precision diagnostics and research

Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases


Teva and Royalty Pharma partner in $500 million deal to fast-track vitiligo treatment
Clinical Trials | January 12, 2026

Teva and Royalty Pharma partner in $500 million deal to fast-track vitiligo treatment

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding


4Moving Biotech bags FDA nod to launch US trial of groundbreaking osteoarthritis therapy
Drug Approval | January 12, 2026

4Moving Biotech bags FDA nod to launch US trial of groundbreaking osteoarthritis therapy

Preclinical studies show that 4P004 modulates multiple biological markers across the joint, potentially slowing structural damage while improving function